MEDLINE Journals

    Use of Neo-melubrina, a banned antipyretic drug, in San Diego, California: a survey of patients and providers.

    Taylor L, Abarca S, Henry B, et al. 
    West J Med 2001 Sep; 175(3) :159-63.

    Dipyrone is an antipyretic drug that has been associated with agranulocytosis. It is banned in the United States but is available in Mexico under the name Neo-melubrina.To define the use of Neo-melubrina in the Hispanic population of 2 San Diego, California, community clinics and to determine local physicians' and nurse practitioners' awareness of the drug and its risks.Patient survey and provider survey.Patients: 200 parents of Hispanic pediatric patients. Providers: members of San Diego chapters of the American Academy of Pediatrics, the American Academy of Family Physicians, and the California Coalition of Nurse Practitioners.Self-reported use of Neo-melubrina by patients, and provider awareness of Neo-melubrina and its most significant side effects.Of the 200 patients, 76 (38.0%) reported a lifetime use of Neo-melubrina. Most (56%) used it for both pain and fever. Most providers were unable to correctly identify why Neo-melubrina might be used or its adverse effects. Physicians answered correctly more often than nurse practitioners and pediatric providers more often than family medicine providers. Providers who trained within 75 miles of the US-Mexico border, who reported a patient population of more than 50% Hispanic, and who were resident physicians at the time of the survey were most likely to answer correctly.Neo-melubrina has been used by a substantial percentage of Hispanic patients in the community clinics surveyed. Many San Diego health care providers are unaware of this medication and may, therefore, miss opportunities to educate patients about safer alternatives.

    Anti-Inflammatory Agents, Non-Steroidal
    Child, Preschool
    Cross-Sectional Studies
    Data Collection
    Drug Utilization
    Drug and Narcotic Control
    Health Knowledge, Attitudes, Practice
    Health Personnel
    Hispanic Americans
    Nonprescription Drugs


    Pub Type(s)
    Comment Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
    PubMed ID


    Content Manager
    Related Content

    A binational comparison of HIV provider attitudes towards the use of complementary and alternative medicine among HIV-positive Latino patients receiving care in the US-Mexico border region.

    Chlamydia trachomatis infection among Hispanic women in the California-Mexico border area, 1993: establishing screening criteria in a primary care setting.

    Metamizole use by Latino immigrants: a common and potentially harmful home remedy.

    Agranulocytosis and near fatal sepsis due to 'Mexican aspirin' (dipyrone).

    Dipyrone-induced granulocytopenia: a case for awareness.

    Dipyrone (metamizole) use in the United States: a lethal tango?

    Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.

    Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.